Primary endpoint: composite MACE (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke)
BPC-157 is sold strictly for laboratory research use only and is not intended for human consumption, medical use, or therapeutic application
June 30, 2026 Key Takeaways The Bioavailability Challenge: Stand
Some of these might include changes in your skin color, intense itching, inflammation of the sac-like covering around your heart, build-up of fluid around your heart, fluid in your lungs, heart valve hardening, brain dysfunction, imbalance of bodily salts, heart disease, and inflammation of the pancreas associated with uremia
This can be administered once or twice a week